FARMINGDALE, N.Y., June 30, 2021 /PRNewswire/ — Codagenix Inc., a clinical-stage synthetic biology company pioneering a novel platform for vaccines and oncolytic virus therapies, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results